What is Hashimoto's thyroiditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Hashimoto's Thyroiditis?

Hashimoto's thyroiditis is a chronic autoimmune disease where the immune system attacks and destroys the thyroid gland through lymphocytic infiltration, making it the most common cause of hypothyroidism in iodine-sufficient regions and affecting women 7-10 times more frequently than men. 1, 2, 3

Pathophysiology and Mechanism

  • The disease results from a loss of immunological tolerance triggered by a combination of genetic susceptibility and environmental factors, leading to autoimmune destruction of thyroid tissue 3, 4
  • Both cellular (T-cell mediated) and humoral (antibody-mediated) immunity drive the pathologic process 5, 4
  • Histologically, the thyroid shows lymphoplasmacytic infiltration with lymphoid follicle formation, germinal centers, parenchymal atrophy, and eventual fibrosis 3, 4
  • The progressive destruction causes the thyroid gland to shrink and ultimately leads to hypothyroidism in most cases 6

Clinical Presentation and Diagnosis

  • Patients typically present with symptoms of hypothyroidism including unexplained fatigue, weight gain, hair loss, cold intolerance, constipation, and depression 1
  • Diagnosis requires TSH testing as the initial screening test, followed by free T4 measurement if TSH is abnormal 1, 2
  • Positive serum antibodies against thyroid peroxidase (TPO) and thyroglobulin confirm the autoimmune etiology 1, 4
  • Multiple tests over 3-6 months should confirm persistently abnormal findings before initiating treatment 1

Associated Autoimmune and Systemic Conditions

A critical pitfall is failing to recognize that Hashimoto's thyroiditis frequently coexists with other autoimmune disorders, requiring broader clinical vigilance:

  • Autoimmune thyroid disease is the most common concurrent autoimmune condition in various patient populations, accounting for 10-23% of associated disorders 1
  • Type 1 diabetes mellitus commonly coexists with Hashimoto's thyroiditis 1, 2
  • Systemic lupus erythematosus occurs in approximately 2.2-2.8% of patients 1, 2
  • Other associations include rheumatoid arthritis, Sjögren syndrome, and inflammatory bowel disease 1
  • Metabolic abnormalities including insulin resistance and type 2 diabetes are also associated 2

Important Clinical Considerations

  • Many patients with Hashimoto's thyroiditis experience persistent symptoms and reduced quality of life even when thyroid function tests are normal (euthyroid state) 2, 7
  • These euthyroid patients may still suffer from neuropsychological deficits, decreased cardiac performance, gastrointestinal disorders, fibromyalgia, and reproductive issues 7
  • The disease can progress through phases: some patients initially experience hyperthyroidism (Hashitoxicosis) before developing hypothyroidism 1
  • A potential relationship exists between Hashimoto's thyroiditis and papillary thyroid cancer, though this correlation requires further investigation 3, 4

Treatment Approach

  • The primary treatment for hypothyroidism resulting from Hashimoto's thyroiditis is daily oral levothyroxine (synthetic T4) replacement therapy 8, 3
  • When both adrenal insufficiency and hypothyroidism are present, steroids must always be started before thyroid hormone to prevent adrenal crisis 1
  • Regular monitoring of thyroid function during levothyroxine therapy is required to maintain optimal dosing 2
  • Liothyronine (T3) can be used as an alternative in patients allergic to desiccated thyroid or thyroid extract 8
  • Thyroid function should be monitored at 2-4 month intervals during treatment and regularly for 1 year after any treatment changes 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hashimoto's Thyroiditis: Clinical Implications and Associations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy.

Best practice & research. Clinical endocrinology & metabolism, 2019

Research

Pathogenesis Markers of Hashimoto's Disease-A Mini Review.

Frontiers in bioscience (Landmark edition), 2022

Research

Hashimoto's thyroiditis in patients with normal thyroid-stimulating hormone levels.

Expert review of endocrinology & metabolism, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.